Posts by: Forest Ray PhD

Forest Ray PhD

Forest Ray received his PhD in systems biology from Columbia University, where he developed tools to match drug side effects to other diseases. He has since worked as a journalist and science writer, covering topics from rare diseases to the intersection between environmental science and social justice. He currently lives in Long Beach, California.

March 5, 2021March 5, 2021

Low-cost, Topical Insulin Drops Show Promise for Hard-to-treat NK

News

Topical insulin drops show promise in successfully treating refractory, or difficult-to-treat, neurotrophic keratitis (NK), according to a recent study. Although more studies are needed to verify this result, the medication’s ... Read more

January 27, 2021January 27, 2021

COVID-19 Vaccines Pose Little Risk to Rare Disease Patients, FDA, CDC Say

News, syndicated

The two COVID-19 vaccines that recently received emergency approval from the U.S. and other worldwide regulatory agencies are expected to pose little risk to the rare disease community, including to ... Read more

October 2, 2020October 2, 2020

New 3D Model Used to Examine Corneal Nerve Growth

News

A new 3D model of the cornea — the eye’s outer layer — is life-like enough that it could be helpful for a variety of research uses, including screening multiple ... Read more

September 18, 2020September 18, 2020

Oxervate Leads to Long-term Restoration of Corneal Sensitivity in 3 NK Patients

News

Oxervate (cenegermin) eye drops healed corneal lesions and increased corneal sensitivity over the long term in cases of hard-to-treat neurotrophic keratitis (NK), according to a recent case series. This increased ... Read more

September 4, 2020September 4, 2020

Same But Different Photo Contest Celebrates People With Rare Diseases

News, syndicated

Same But Different, a U.K. nonprofit that uses the arts to bring communities together, is holding a calendar photography competition to raise awareness for rare diseases. Under the theme “A ... Read more

August 28, 2020August 28, 2020

Xperiome Platform Aims to Streamline Searches for Rare Diseases, Gain Patient Input

News, syndicated

Raremark, an online rare disease patient community, has launched a digital platform called Xperiome, aimed at streamlining the search for new medicines for rare disorders and incorporating more patient input ... Read more

July 31, 2020July 31, 2020

Dompé Grants Tanner Pharma Exclusive Oxervate Distribution Rights in Certain Countries

News

Dompé and Tanner Pharma Group entered into an agreement for the distribution of Oxervate (cenegermin), used in the treatment of neurotrophic keratitis (NK). The agreement grants Tanner exclusive rights to distribute ... Read more

July 10, 2020July 10, 2020

National Survey Seeks to Assess Full Social, Economic Burdens of Rare Diseases in US

News, syndicated

The EveryLife Foundation for Rare Diseases has launched a nationwide National Burden of Rare Disease Survey to measure the full implications, economic and social, of living with rare disease in ... Read more

June 26, 2020June 26, 2020

Oxervate Eyedrops Improve Corneal Sensitivity in NK, Trials Show

News

Oxervate (cenegermin) eyedrops improved corneal sensitivity in people with neurotrophic keratitis (NK), according to the results of two Phase 2 trials. Those results had been expected to be presented at the ... Read more

June 22, 2020July 28, 2020

Alexion Charitable Foundation Giving $1.1M to Assist Rare Disease Community During Pandemic

News, syndicated

The Alexion Charitable Foundation has awarded $1.1 million in grants to programs that support those with rare diseases during the COVID-19 pandemic, the organization recently announced. The grants will support ... Read more